Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 1

A Single Dose, Phase 1 Study of JADE101 in Healthy Japanese and Chinese Participants

Jade Biosciences, Inc. · NCT07525947

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–55 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Phase 1
Target enrollment
40
US sites recruiting
1
Study start
May 1, 2026
Record last updated
June 4, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This is a Phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of JADE101 in healthy Japanese and Chinese participants.

Being studied: JADE101

Conditions: Healthy Volunteers (HV)

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Healthy male or female participants 18-55 years of age, inclusive
  • First-generation Japanese or Chinese participants born in Japan/China
  • A body weight between 40-100 kg and a body mass index (BMI) between 18.0 - 32.0 kg/m2 (all inclusive) at screening
  • Willing and able to comply with the study site stay, scheduled visits, and study procedures
  • Willing and able to comply with contraceptive and lifestyle requirements from admission through the end of the study

Exclusion Criteria

  • Harmful alcohol use
  • Smoking/vaping or heavy tobacco use within 2 years prior to screening
  • Known history of abuse of illicit drugs
  • Nursing, lactating or pregnant, or who have plans to become pregnant during the study
  • Known history of clinically significant disease
  • Known history of immunodeficiency disorder
  • History of clinically significant allergic reactions or hypersensitivity

Recruiting US locations

  • Parexel Early Phase Clinical Unit (EPCU)

    Glendale, CA 91206

    Site contact: Han · +1-888-228-7425 · study.losangeles@parexel.com

Study contacts (from the official record)

  • Han · +1-888-228-7425 · study.losangeles@parexel.com
All healthy volunteers studies in California →
A Single Dose, Phase 1 Study of JADE101 in Healthy Japanese and… (NCT07525947) | Bored Studies